Incidence of complications in insulin-dependent diabetes mellitus: A survival analysis

American Journal of Epidemiology

Volumn 143, Issue 5, 1996, Pages 431-441

  Lloyd, Cathy E ^a   Becker, Dorothy ^b   Ellis, Demetrius ^b   Orchard, Trevor J ^a,b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

coronary disease; diabetes mellitus, insulin dependent; diabetic nephropathies; diabetic neuropathies; diabetic retinopathy; survival analysis

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; SURVIVAL TIME; TREATMENT OUTCOME; UNITED STATES;

EID: 0029866098     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a008763     Document Type: Article

References (29)

1. Lloyd CE, Orchard TJ. Insulin dependent diabetes mellitus in young people: the epidemiology of physical and psychosocial complications. In: Marshall SM, Home PD, Alberti KGMM, et al, eds. The diabetes annual. Amsterdam: Elsevier Scientific Publications, 1993;7:211-44.
2. American Diabetes Association. Direct and indirect costs of diabetes in the United States in 1992. Alexandria, VA: American Diabetes Association, 1993.
3. Feldt-Rasmussen B, Mathiesen ER, Hegedus L, et al. Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. N Engl J Med 1986;314:665-70.
4. Lauritzen T, Frost-Larsen K, Larsen HW, et al. Two-year subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985;34(suppl 3):74-9.
5. Brinchman-Hansen O. Dahl-Jorgensen K, Hanssen KF, et al. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps and conventional insulin therapy. Arch Opthalmol 1988;106:1242-6.
6. Kroc Collaborative Study Group. Blood glucose control and the evolution of diabetic retinopathy and albuminuria: a preliminary multicenter trial. N Engl J Med 1984;311:365-72.
7. Wang PH, Law J, Chalmus TC Meta-analysis of effects of intensive blood-glucose control on late complications of type 1 diabetes. Lancet 1993;341:1306-9.
8. Brinchmann-Hansen O, Dahl-Jorgensen K, Sandvik L, et al. Blood glucose concentrations and progression of diabetic retinopathy: the 7 year results of the Oslo study. Br Med J 1992;304:19-22.
9. Reichard P, Nilsson BY, Rosenquist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 1993;329:304-9.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329: 977-86.
11. Wagener DK, Sacks JM, LaPorte RE, et al. The Pittsburgh study of insulin-dependent diabetes mellitus: risk for diabetes among relatives of IDDM. Diabetes 1982;31:136-44.
12. Orchard TJ, Dorman JS, Maser RE, et al. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 1990;39:1116-24.
13. Borhani NO, Kass EH, Langford HG, et al. The Hypertension Detection and Follow-up Program. Prev Med 1976;5:207-15.
14. Early Treatment of Diabetic Retinopathy Study Coordinating Center. Manual of operations. Baltimore, MD: University of Maryland School of Medicine, 1980, chapter 5:18.
15. DCCT Research Group. Manual of operations for the Diabetes Control and Complications Trial. Washington DC: US Department of Commerce, 1987.
16. Orchard TJ, CCSP Investigators. Validation of coronary heart disease mortality data: the Community Cardiovascular Surveillance Project Pilot Experience. Am Heart Assoc Cardiovasc Dis Epidemiol Newslett 1985;157:46.
17. Dixon WJ, ed. BMDP statistical software manual. Vol 2. Berkeley, CA: California University Press, 1992:795-823.
18. Kingsley LA, Dorman JS, Doft BH, et al. An epidemiologic approach to the study of retinopathy: the Pittsburgh Diabetic Morbidity and Retinopathy Studies. Diabetes Res Clin Pract 1988; 4:99-109.
19. Kahn HA, Sempos CT. Statistical methods in epidemiology. New York: Oxford University Press, 1989:193-8.
20. Lloyd CE, Kuller L. Predictors of macrovascular complications in insulin-dependent diabetes mellitus (IDDM). (Abstract). Diabetes 1994;43(suppl 1):99A.
21. Gilbert RE, Tsalamandris C, Bach LA, et al. Long-term glycemic control and rate of progression of early diabetic kidney disease. Kidney Int 1993;44:855-9.
22. McCance DR, Atkinson AB, Hadden DR, et al. Long-term glycemic control and neurological function in IDDM patients. Diabetes Care 1993;16:1291-3.
23. Dahl-Jorgensen K, Bjoro T, Kierulf P, et al. Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 1992;41:920-3.
24. Kullberg CE, Arnqvist HJ. Elevated long-term glycated haemoglobin precedes proliferative retinopathy and nephropathy in Type 1 (insulin-dependent) diabetic patients. Diabetologia 1993;36:961-5.
25. Goldstein DE, Blinder KJ, Ide CH, et al. Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Results of a 12-year longitudinal study. Ophthalmology 1993;100:1125-32.
26. Kostraba JN, Dorman JS, Orchard TJ, et al. Contribution of diabetes duration before puberty to development of microvascular complications in Type 1 diabetes subjects. Diabetes Care 1989;12:686-93.
27. Cruickshanks KJ, Orchard TJ, Becker DJ. The cardiovascular risk profile of adolescents with insulin-dependent diabetes mellitus. Diabetes Care 1985;8:118-24.
28. D'Antonio JA, Ellis D, Doft BH, et al. Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study status report after 5 yr of Type 1 diabetes. Diabetes Care 1989;12:694-700.
29. Torffvit O, Agardh CD. The predictive value of albuminuria for cardiovascular and renal disease. A 5-year follow-up study of 476 patients with type 1 diabetes mellitus. J Diabetes Complications 1993;7:49-56.